Antibacterial Agents TRIZ Cases

Partial disulfide reduction creates reactive thiols for selective drug conjugation on antibody molecules.

Antioxidants and silica gel desiccants protect difimicin from humidity-induced oxidation, maintaining at least 90% purity during storage.

Local hydrophilic residue modifications grant water solubility to a bioactive cyclo-heptapeptide that inhibits Staphylococcus aureus toxins.

High-affinity binding proteins inhibit the NetB toxin, preventing necrotic enteritis without triggering antimicrobial resistance.

Specific chemical intermediaries modulate the GacS/GacA phosphorelay mechanism to reduce persistent infection severity.

Cationic lipid-peptide conjugates form stable complexes with nucleic acids via electrostatic interaction to enable targeted cellular delivery.

Iron complex compounds alter gut chemistry to inhibit bacterial growth, preventing antibiotic resistance development.

A lactobionic acid and hyaluronic acid composition delivers topical antimicrobial action against ocular pathogens.

Specific structural modifications reduce cytotoxicity to intact cells while maintaining inhibitory effects on proliferative diseases.

Specific gyrase and topoisomerase IV inhibitors overcome drug resistance in tuberculosis while maintaining favorable toxicological profiles.

Ligand-inducible chimeric signaling molecules control T cell proliferation, reducing toxic side effects and off-target toxicity in CAR therapies.

Engineered antibodies bind domain 3 of IL1RAP to inhibit signaling pathways, resolving insufficient binding specificity in current therapies.

Inhaled GM-CSF activates macrophages and neutrophils to clear pathogens, addressing insufficient host defense in pulmonary diseases.

Chimeric adenoviral vectors incorporate heterologous dsRNA as a TLR3 agonist, increasing antibody titers and CD8+ T cell responses.

Sialic acid precursors supplement defective cell lines to produce highly active glycoproteins with optimized sialylation.

Immobilizing serrathiopeptidase on pyrogenic silica resolves the contradiction between antibacterial activity and necrosis inhibition in festering wounds.

Formula I compounds inhibit bacterial peptide deformylase to treat infections while minimizing human cell toxicity.

Isolated surface proteins elicit cross-reactive antibodies to protect against heterologous serotypes without separate formulations.

Segmented chitosan and fibroin layers resolve mechanical strength versus manufacturing complexity trade-offs in biodegradable polymer fabrication.

Novel pyrrole sulfonamide derivatives act as potassium-competitive acid blockers to rapidly inhibit gastric acid secretion.

Iodide and hydrogen peroxide intra-mammary treatment eliminates mastitis biofilms without antibiotic residues, preventing milk discard.

Polyclonal bispecific binding molecules redirect cytotoxic immune cells to eliminate pathogen-infected host cells.

Baking calcium shells at high temperatures creates baked shell powder that strengthens antibacterial effects and extends therapeutic duration for skin diseases.

Topical antibacterial composition containing clindamycin or erythromycin prevents Propionibacterium acnes infections during shoulder surgery.

Defined dimeric linkers increase affinity and stability while eliminating the non-uniform composition of polymeric ligands.

Synthesizing a pyridine derivative via one-pot four-component reaction overcomes antibiotic resistance through segmented molecular design.

Synthesized via transition metal catalysis, these compounds treat carbapenem-resistant Acinetobacter baumannii infections.

A 2-benzo-[3,4-b]pyridine-[b,g]indeno[1,2-d]oxonine-tetraone compound synthesized using 1,3-diaminopropan-2-ol as a green catalyst.

Aerosolized EDTA at pH 8.5 to 11 delivers antimicrobials locally to the lungs, reducing systemic absorption and drug resistance risks.

A fluorinated pyridine derivative compound synthesized via a one-pot four-component reaction.

A multivalent prodrug carrier attaches multiple parent drug molecules to extend release duration.

Myoviridae bacteriophage Vib-PAP-7 infects and lyses Vibrio parahaemolyticus cells to eliminate the pathogen.

Interferential microwave fields distribute energy uniformly across organic materials, reducing arcing and improving dehydration speed.

Purified polypeptides form complexes with specific antibodies to detect Anaplasma phagocytophilum infections in biological samples.

Nanoparticles convert infrared initiation energy into higher energy radiation to modify target biological structures in situ.

Branched polyethylenimine binds MRSA cell walls, restoring antibiotic susceptibility and reducing minimum inhibitory concentration against resistant strains.

Modifying benzoate substituent groups improves therapeutic reliability while eliminating adverse side effects from steroidal treatments.

Small molecule analogs replicate protein functions to treat inflammatory diseases without immunoreactivity.

Primary pathogen vaccination triggers cross-protective immunity, reducing clinical severity and lung lesions from dual CIV and S. equi challenges.

Single high doses of fusidic acid treat gonococcal infections while minimizing nausea and vomiting risks.

A flavouring composition combines 3,4-dimethylphenol with specific antimicrobial ingredients to deliver targeted antibacterial action.

Pellet compositions use a wax-like agent to achieve sustained release, eliminating coating complexity while maintaining therapeutic levels.

Modified CAP37 peptides resolve scalability and purity bottlenecks by incorporating arginine residues to achieve 5-log bacterial reduction.

Optimized bulk density ratio maintains uniform plug-flow, resolving uneven retention times and low yield.

Fusion proteins expressing IL-2R beta chains provide self-sufficient signaling to overcome tumor microenvironment toxicity and enhance T cell persistence.

A composite essential oil blend using camellia oil and plant extracts to deliver targeted antibacterial action.